Neutralizing antibodies against HIV infection
US6030772A · kind A · utility
15Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 11, 1998 |
| Grant date | Feb 29, 2000 |
| Priority date | — |
| Expiry date | May 11, 2018 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/975
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Neutralizing antibodies against HIV infection are provided. The antibodies are reactive with cryptic epitopes on gp120 and/or CD4 induced by the formation of immunogenic complexes comprising gp120 covalently bonded to CD4 or to succinyl concanvalin A.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.